{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:24:04Z","timestamp":1784996644369,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00894-018-3756-y","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T14:56:08Z","timestamp":1533653768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-5134","authenticated-orcid":false,"given":"Josiane V.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo B.","family":"Serafim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel M.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Giuliatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn M. C.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moys\u00e9s F.","family":"Ara\u00fajo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco H. A.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlton A.","family":"Taft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H. T. P.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleydson B. R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"3756_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1590\/S1809-29502008000200005","volume":"15","author":"LRF Ferreira","year":"2008","unstructured":"Ferreira LRF, Pestana PR, de Oliveira J, Mesquita-Ferrari RA (2008) Effects of aquatic rehabilitation on symptoms and quality of life in rheumatoid arthritis female patients. Fisioterapia e Pesquisa 15:136\u2013141. \n                    https:\/\/doi.org\/10.1590\/S1809-29502008000200005","journal-title":"Fisioterapia e Pesquisa"},{"key":"3756_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.rbr.2015.08.004","volume":"55","author":"LMH Mota","year":"2015","unstructured":"Mota LMH, Cruz BA, De Albuquerque CP, Gon\u00e7alves DP, Laurindo IMM, Pereira IA, De Carvalho JF, Pinheiro GRC, Bertolo MB, Pinto MRC, Louzada-Junior P, Xavier RM, Giorgi RDN, Lima RAC (2015) Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib. Rev. Bras. Reumatol. 55:512\u2013521. \n                    https:\/\/doi.org\/10.1016\/j.rbr.2015.08.004","journal-title":"Rev. Bras. Reumatol."},{"key":"3756_CR3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/ard.2002.004861","volume":"62","author":"AMJ Chorus","year":"2003","unstructured":"Chorus AMJ, Miedema HS, Boonen A, Linden SVD (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann. Rheum. Dis. 62:1178\u20131184. \n                    https:\/\/doi.org\/10.1136\/ard.2002.004861","journal-title":"Ann. Rheum. Dis."},{"key":"3756_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/rheumatology\/40.10.1112","volume":"40","author":"GJ Tijhuis","year":"2001","unstructured":"Tijhuis GJ, Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LMA, Hazes JMW, Vliet Vlieland TPM (2001) The validity of the rheumatoid arthritis quality of life (RAQoL) questionnaire. Rheumatology 40:1112\u20131119. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/40.10.1112","journal-title":"Rheumatology"},{"key":"3756_CR5","volume-title":"Pharmacology for the physical therapist","author":"PC Panus","year":"2011","unstructured":"Panus PC, Katzung B, Jobst EE, Tinsley SL, Marsters SB, Trevor AJ (2011) Pharmacology for the physical therapist. Artmed, Porto Alegre"},{"key":"3756_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.chembiol.2015.07.017","volume":"22","author":"P Canning","year":"2015","unstructured":"Canning P, Ruan Q, Schwerd T, Hrdinka M, Maki JL, Saleh D, Suebsuwong C, Ray S, Brennan PE, Cuny GD, Uhlig HH, Gyrd-Hansen M, Degterev A, Bullock AN (2015) Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors. Chem. Biol. 22:1174\u20131184. \n                    https:\/\/doi.org\/10.1016\/j.chembiol.2015.07.017","journal-title":"Chem. Biol."},{"key":"3756_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"J Berman","year":"2000","unstructured":"Berman J, Westbrook Z, Feng G, Gilliland TN, Bhat H, Weissig IN, Shindyalov Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res. 28:235\u2013242. \n                    https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res."},{"key":"3756_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson MK, Tiqing Liu MB, Nicola G, Hwang L, Chong J (2016) BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44:1045\u20131053. \n                    https:\/\/doi.org\/10.1093\/nar\/gkv1072","journal-title":"Nucleic Acids Res."},{"key":"3756_CR9","doi-asserted-by":"publisher","unstructured":"Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharmacol 195\u2013204. \n                    https:\/\/doi.org\/10.1016\/S0928-0987(00)00076-2","DOI":"10.1016\/S0928-0987(00)00076-2"},{"key":"3756_CR10","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"16","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 16:2785\u20132791. \n                    https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J. Comput. Chem."},{"key":"3756_CR11","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1038\/ncomms7442","volume":"6","author":"U Nachbur","year":"2015","unstructured":"Nachbur U, Stafford CA, Bankovacki A, Zhan Y, Lindqvist LM, Fiil BK, Khakham Y, Ko H, Sandow JJ, Falk H, Holien JK, Chau D, Hildebrand J, Vince JE, Sharp PP, Webb AI, Jackman KA, Hlen SM, Kennedy CL, Lowes KN, Murphy JM, Gyrd-Hansen M, Parker MW, Hartland EL, Lew AM, Huang DCS, Lessene G, Silke J (2015) A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat. Commun. 6:6442. \n                    https:\/\/doi.org\/10.1038\/ncomms7442","journal-title":"Nat. Commun."},{"key":"3756_CR12","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.2174\/1381612821666150528121423","volume":"21","author":"CBR Santos","year":"2015","unstructured":"Santos CBR, Lobato CC, Braga FS, Costa JS, Favacho HAS, Carvalho JCT, Mac\u00eado WJC, Brasil DSB, Silva CHTP, Hage-Melim LIS (2015) Rational design of antimalarial drugs using molecular modeling and statistical analysis. Curr. Pharm. Des. 21:4112\u20134127. \n                    https:\/\/doi.org\/10.2174\/1381612821666150528121423","journal-title":"Curr. Pharm. Des."},{"key":"3756_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/molecules19010367","volume":"19","author":"CBR Santos","year":"2013","unstructured":"Santos CBR, Vieira JB, Lobato CC, Hage-Melim LIS, Souto RNP, Lima CS, Costa EVM, Brasil DSB, Mac\u00eado WJC, Carvalho JCT (2013) A SAR and QSAR study of new artemisinin compounds with antimalarial activity. Molecules 19:367\u2013399. \n                    https:\/\/doi.org\/10.3390\/molecules19010367","journal-title":"Molecules"},{"key":"3756_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/cmb.2007.0130","volume":"15","author":"D Schneidman-Duhovny","year":"2008","unstructured":"Schneidman-Duhovny D, Dror O, Inbar Y, Nussinov R, Wolfson JH (2008) Deterministic pharmacophore detection via multiple flexible alignments of drug-like molecules. J. Comput. Biol. 15:737\u2013754. \n                    https:\/\/doi.org\/10.1089\/cmb.2007.0130","journal-title":"J. Comput. Biol."},{"key":"3756_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/nar\/gkn187","volume":"36","author":"D Schneidman-Duhovny","year":"2008","unstructured":"Schneidman-Duhovny D, Dror O, Inbar Y, Nussinov R, Wolfson HJ (2008) PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res. 36:223\u2013228. \n                    https:\/\/doi.org\/10.1093\/nar\/gkn187","journal-title":"Nucleic Acids Res."},{"key":"3756_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/nar\/gks378","volume":"40","author":"DR Koes","year":"2012","unstructured":"Koes DR, Camacho CJ (2012) ZINCPharmer: pharmacophore search of the ZINC database. Nucleic Acids Res. 40:409\u2013414. \n                    https:\/\/doi.org\/10.1093\/nar\/gks378","journal-title":"Nucleic Acids Res."},{"key":"3756_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2298\/JSC111227111B","volume":"76","author":"JP Barbosa","year":"2011","unstructured":"Barbosa JP, Ferreira JEV, Figueiredo AF, Almeida RCO, Silva OPP, Carvalho JRC, Cristino MGG, Ciriaco-Pinheiro J, Vieira JLF, Serra RTA (2011) Molecular modeling and chemometric study of anticancer derivatives of artemisinin. J. Serb. Chem. Soc. 76:1263\u20131282. \n                    https:\/\/doi.org\/10.2298\/JSC111227111B","journal-title":"J. Serb. Chem. Soc."},{"key":"3756_CR18","unstructured":"STATISTICA (Data Analysis Software System) (2004) Version 6.1, StatSoft, Inc."},{"key":"3756_CR19","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1166\/jctn.2015.4260","volume":"12","author":"EL Cunha","year":"2015","unstructured":"Cunha EL, Santos CF, Braga FS, Costa JS, Silva RC, Favacho HAS, Hage-Melim LIS, Carvalho JCT, Silva CHTP, Santos CBR (2015) Computational investigation of antifungal compounds using molecular modeling and prediction of ADME\/Tox properties. J. Comput. Theor. Nanosci. 12:3682\u20133691. \n                    https:\/\/doi.org\/10.1166\/jctn.2015.4260","journal-title":"J. Comput. Theor. Nanosci."},{"key":"3756_CR20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/ml400382p","volume":"4","author":"PA Harris","year":"2013","unstructured":"Harris PA, Bandyopadhyay D, Berger SB, Campobasso N, Capriotti CA, Cox JA, Dare L, Finger JN, Hoffman SJ, Kahler KM, Lehr R, Lich JD, Nagilla R, Nolte RT, Ouellette MT, Pao CS, Schaeffer MC, Smallwood A, Sun HH, Swift BA, Totoritis RD, Ward P, Marquis RW, Bertin J, Gough PJ (2013) Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis. Med Chem Lett. 4:1238\u20131243. \n                    https:\/\/doi.org\/10.1021\/ml400382p","journal-title":"Med Chem Lett."},{"key":"3756_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.celrep.2013.08.044","volume":"5","author":"T Xie","year":"2013","unstructured":"Xie T, Peng W, Yan C, Wu J, Gong X, Shi Y (2013) Structural insights into RIP3-mediated necroptotic signaling. Cell Rep. 5:70\u201378. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2013.08.044","journal-title":"Cell Rep."},{"key":"3756_CR22","unstructured":"Dassault Syst\u00e8mes BIOVIA (2015) Discovery studio modeling environment. San Diego"},{"key":"3756_CR23","unstructured":"Dassault Syst\u00e8mes BIOVIA (2018) Discovery Studio 4.0, San Diego"},{"key":"3756_CR24","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1021\/jp982007x","volume":"102","author":"B Jayaram","year":"1998","unstructured":"Jayaram B, Sprous D, Beveridge DL (1998) Solvation free energy of biomacromolecules: parameters for a modified generalized born model consistent with the AMBER force field. J. Phys. Chem. B 102:9571\u20139576. \n                    https:\/\/doi.org\/10.1021\/jp982007x","journal-title":"J. Phys. Chem. B"},{"key":"3756_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspect. Drug Discovery Des. 18:113\u2013135. \n                    https:\/\/doi.org\/10.1023\/A:1008763014207","journal-title":"Perspect. Drug Discovery Des."},{"key":"3756_CR26","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.1021\/ja981844+","volume":"120","author":"J Srinivasan","year":"1998","unstructured":"Srinivasan J, Cheatham TE, Cieplak P, Kollman PA, Case DA (1998) Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helixes. J. Am. Chem. Soc. 120:9401\u20139409. \n                    https:\/\/doi.org\/10.1021\/ja981844","journal-title":"J. Am. Chem. Soc."},{"key":"3756_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 1:19\u201325. \n                    https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX."},{"key":"3756_CR28","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1021\/jp984217f","volume":"103","author":"WRP Scott","year":"1999","unstructured":"Scott WRP, H\u00fcnenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Kruger P, Van Gunsteren WF (1999) The GROMOS biomolecular simulation program package. J. Phys. Chem. A 103:3596\u20133607. \n                    https:\/\/doi.org\/10.1021\/jp984217f","journal-title":"J. Phys. Chem. A"},{"key":"3756_CR29","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A 105:9954\u20139960. \n                    https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J. Phys. Chem. A"},{"key":"3756_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00355047","volume":"10","author":"DM Aalten Van","year":"1996","unstructured":"Van Aalten DM, Bywater R, Findlay JB, Hendlich M, Hooft RW, Vriend G (1996) PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J. Comput. Aided Mol. Des. 10:255\u2013262. \n                    https:\/\/doi.org\/10.1007\/BF00355047","journal-title":"J. Comput. Aided Mol. Des."},{"key":"3756_CR31","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1021\/ci100335w","volume":"50","author":"JA Lemkul","year":"2010","unstructured":"Lemkul JA, Allen WJ, Bevan DR (2010) Practical considerations for building GROMOS-compatible small-molecule topologies. J. Chem. Inf. Model. 50:2221\u20132235. \n                    https:\/\/doi.org\/10.1021\/ci100335w","journal-title":"J. Chem. Inf. Model."},{"key":"3756_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14:33\u201338. \n                    https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J. Mol. Graph."},{"key":"3756_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/07391102.2016.1277163","volume":"36","author":"ALE Pereira","year":"2017","unstructured":"Pereira ALE, Santos GBF, Franco MSF, Federico LB, Silva CHTP, Santos CBR (2017) Molecular modeling and statistical analysis in the design of derivatives of human dipeptidyl peptidase IV. J. Biomol. Struct. Dyn. 36:318\u2013334. \n                    https:\/\/doi.org\/10.1080\/07391102.2016.1277163","journal-title":"J. Biomol. Struct. Dyn."},{"key":"3756_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5935\/0100-4042.20160065","volume":"39","author":"MG Birck","year":"2016","unstructured":"Birck MG, Campos LJ, Melo EB (2016) Estudo computacional de 1h-imidazol-2-il-pirimidina-4,6-diaminas para a identifica\u00e7\u00e3o de potenciais precursores de novos agentes antimal\u00e1ricos. Quim Nova 39:567\u2013574. \n                    https:\/\/doi.org\/10.5935\/0100-4042.20160065","journal-title":"Quim Nova"},{"key":"3756_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/291214","volume":"2014","author":"S Gupta","year":"2014","unstructured":"Gupta S, Mohan CG (2014) Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening. Biomed. Res. Int. 2014:1\u201321. \n                    https:\/\/doi.org\/10.1155\/2014\/291214","journal-title":"Biomed. Res. Int."},{"key":"3756_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/molecules190810670","volume":"19","author":"JB Vieira","year":"2014","unstructured":"Vieira JB, Braga FS, Lobato CC (2014) A QSAR, pharmacokinetic and toxicological study of new artemisinin compounds with anticancer activity. Molecules 19:670\u2013679. \n                    https:\/\/doi.org\/10.3390\/molecules190810670","journal-title":"Molecules"},{"key":"3756_CR37","doi-asserted-by":"publisher","unstructured":"Ames BN, Gurney EG, Miller AJ, Bartsch H (1972) Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc. Natl. Acad. Sci. U. S. A. 69:3128\u20133132. \n                    https:\/\/doi.org\/10.1073\/pnas.69.11.3128","DOI":"10.1073\/pnas.69.11.3128"},{"key":"3756_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.9734\/BJPR\/2015\/17591","volume":"7","author":"NSR Silva","year":"2015","unstructured":"Silva NSR, Santos CF, Gon\u00e7alves LKS, Braga FS, Almeida JR, Lima CS, Brasil DSB, Silva CHTP, Hage-Melim LIS, Santos CBR (2015) Molecular modeling of the major compounds of Sesquiterpenes class in copaiba oil-resin. Br. J. Pharm. Res. 7:247\u2013263. \n                    https:\/\/doi.org\/10.9734\/BJPR\/2015\/17591","journal-title":"Br. J. Pharm. Res."},{"key":"3756_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/molecules23020453","volume":"23","author":"JV Cruz","year":"2018","unstructured":"Cruz JV, Neto MFA, Silva LB, Ramos RS, Costa JS, Brasil DSB, Lobato CC, Costa GV, Bittencourt JAHM, Silva CHTP, Leite FHA, Santos CBR (2018) Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening. Molecules 23:453. \n                    https:\/\/doi.org\/10.3390\/molecules23020453","journal-title":"Molecules"},{"key":"3756_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jep.2018.04.041","volume":"222","author":"CBR Santos Dos","year":"2018","unstructured":"Dos Santos CBR, da Silva RR, Ortiz BLS, da Silva GM, Giuliatti S, Balderas-Lopez JL, Navarrete A, Carvalho JCT (2018) Oil from the fruits of Pterodon emarginatus Vog.: a traditional anti-inflammatory. Study combining in vivo and in silico. J. Ethnopharmacol. 222:107\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.jep.2018.04.041","journal-title":"J. Ethnopharmacol."},{"key":"3756_CR41","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","volume":"10","author":"M Najjar","year":"2015","unstructured":"Najjar M, Suebsuwong C, Ray SS, Thapa RJ, Maki JL, Nogusa S, Shah S, Saleh D, Gough PJ, Bertin J, Yuan J, Balachandran S, Cuny GD, Degterev A (2015) Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep. 10:1850\u20131860. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2015.02.052","journal-title":"Cell Rep."},{"key":"3756_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2012.109","volume":"33","author":"S-s Ou-Yang","year":"2012","unstructured":"Ou-Yang S-s, Lu J-y, Kong X-q, Liang Z-j, Luo C, Hualiang J (2012) Computational drug discovery. Acta Pharmacol. Sin. 33:1131\u20131140. \n                    https:\/\/doi.org\/10.1038\/aps.2012.109","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-018-3756-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:13:50Z","timestamp":1565118830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-018-3756-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3756"],"URL":"https:\/\/doi.org\/10.1007\/s00894-018-3756-y","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"13 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"225"}}